Research News

GW Radiation Oncology is pleased to share the 2021 Annual Report, a summary of our efforts to adapt to the COVID-19 pandemic, address health disparities, and improve diversity and inclusion.

George Washington University (GW) has entered a new $3.2 million corporate research agreement with US Patent Innovations, LLC (USPI) to support further development of adaptive cold plasma devices for cancer therapies and explore using these devices to combat the spread of COVID-19.

Four young researchers at the George Washington University (GW) School of Medicine and Health Sciences (SMHS) were selected as fellows to the recently awarded five-year National Cancer Institute T32 Training Grant.

WASHINGTON (Sept. 9, 2020) - Spironolactone is not associated with increased risk of female breast cancer recurrence, according to research from the George Washington University (GW) Department of Dermatology.

Genetic modifier HDAC6 was found to control tumor growth and halt metastasis in triple-negative breast cancer in vivo, according to a new study published in the top-tier journal Cancer Research by investigators at the George Washington University (GW) Cancer Center.

The National Institutes of Health has awarded $3.6 million to Rebecca Lynch, PhD, assistant professor of microbiology, immunology, and tropical medicine at the George Washington University (GW) School of Medicine and Health Sciences and member of the GW Cancer Center, to investigate HIV-1…

Knowing what cancer survivors value can help providers address gaps in care, improve the care experience, and increase behaviors and practices that support survivors’ ability to accept and manage their post-treatment care, according to focus group findings from researchers at the George Washington…

The George Washington University (GW) School of Medicine and Health Sciences (SMHS) was recently awarded its first-ever National Institutes of Health T-32 research training grant from the National Cancer Institute (NCI) in support of the GW Cancer Biology Training Program.

Enrollment in a supportive oncodermatology program is associated with a significantly improved quality of life score, according to a recent survey from the George Washington University (GW) Cancer Center. The results of the survey were published in the Journal of Drugs in Dermatology.

Findings published in Nanomaterials by a team at GW suggest that a combination of photothermal and epigenetic therapies may help to maximize the therapeutic benefits of melanoma, and possibly other tumors.